Author(s): Pandey B, Shrestha K, Lewis J, Hawksworth RA, Walker SL
Abstract Share this page
Abstract Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients. We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2\% developed DHS and 0.25\% died due to DHS.
This article was published in Trop Doct
and referenced in Journal of Clinical & Experimental Pharmacology